Companies / SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc.
SWTXCIK 1773427
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 9, 2021 | Bain Capital Life Sciences Investors, LLC 10% owner | Sell Open-market sale | Common Stock | $103.67M | -1.4M -19.91% | 5,831,307 | high |
| Mar 1, 2021 | Orbimed Advisors LLC 10% owner | Sell Open-market sale | Common Stock | $101.49M | -1.2M -16.47% | 6,186,307 | high |
| Aug 10, 2021 | Bain Capital Life Sciences Investors, LLC 10% owner | Sell Open-market sale | Common Stock | $70.25M | -1.0M -17.15% | 4,831,307 | high |
| Mar 16, 2023 | Schwartz Jeffrey Lawrence Director | Sell Open-market sale | Common Stock | $49.88M | -1.8M -36.22% | 3,081,307 | high |
| Aug 8, 2022 | Orbimed Advisors LLC 10% owner | Sell Open-market sale | Common Stock | $7.86M | -205K -3.40% | 5,823,307 | medium |
| Jan 19, 2021 | Islam Saqib CEO | Sell Open-market sale | Common Stock | $4.74M | -60K -4.69% | 1,225,196 | medium |
| Sep 12, 2022 | Orbimed Advisors LLC 10% owner | Sell Open-market sale | Common Stock | $3.96M | -124K -2.15% | 5,629,842 | medium |
| Feb 10, 2025 | Lynch Daniel Director | Sell Open-market sale | Common Stock | $3.71M | -70K -22.80% | 236,178 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SWTX | common | 85205L107 |